Noemi Arrighetti

Via Amadeo 42
Milan, 20133, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

USP18 Impacts Cisplatin Resistance in Ovarian Cancer Cells by Modulating DNA Repair.

USP18 Impacts Cisplatin Resistance in Ovarian Cancer Cells by Modulating DNA Repair.

Journal: International journal of biological sciences

Published: December 22, 2025

Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas.

Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas.

Journal: bioRxiv : the preprint server for biology

Published: May 20, 2024

Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas.

Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas.

Journal: The Journal of clinical investigation

Published: May 01, 2024

Targeting EZH2 in SMARCB1-deficient sarcomas: Advances and opportunities to potentiate the efficacy of EZH2 inhibitors.

Targeting EZH2 in SMARCB1-deficient sarcomas: Advances and opportunities to potentiate the efficacy of EZH2 inhibitors.

Journal: Biochemical pharmacology

Published: June 13, 2023

Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy.

Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy.

Journal: bioRxiv : the preprint server for biology

Published: February 17, 2023

Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy.

Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy.

Journal: Cancer discovery

Published: February 06, 2023

The deubiquitinase USP8 regulates ovarian cancer cell response to cisplatin by suppressing apoptosis.

The deubiquitinase USP8 regulates ovarian cancer cell response to cisplatin by suppressing apoptosis.

Journal: Frontiers in cell and developmental biology

Published: September 27, 2022

Caffeic acid phenethyl ester targets ubiquitin-specific protease 8 and synergizes with cisplatin in endometrioid ovarian carcinoma cells.

Caffeic acid phenethyl ester targets ubiquitin-specific protease 8 and synergizes with cisplatin in endometrioid ovarian carcinoma cells.

Journal: Biochemical pharmacology

Published: October 21, 2021

A trifunctional self-immolative spacer enables drug release with two non-sequential enzymatic cleavages.

A trifunctional self-immolative spacer enables drug release with two non-sequential enzymatic cleavages.

Journal: Chemical communications (Cambridge, England)

Published: July 15, 2021

Recent Progresses in Conjugation with Bioactive Ligands to Improve the Anticancer Activity of Platinum Compounds.

Recent Progresses in Conjugation with Bioactive Ligands to Improve the Anticancer Activity of Platinum Compounds.

Journal: Current medicinal chemistry

Published: March 31, 2021

Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma.

Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 08, 2021

miRNAs as Therapeutic Tools and Biomarkers for Prostate Cancer.

miRNAs as Therapeutic Tools and Biomarkers for Prostate Cancer.

Journal: Pharmaceutics

Published: February 19, 2021

Showing 1-12 of 28

Last Updated: 09/26/2026